BENZYL BENZOATE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for benzyl benzoate and what is the scope of patent protection?
Benzyl benzoate
is the generic ingredient in one branded drug marketed by Lannett and is included in one NDA. Additional information is available in the individual branded drug profile pages.Summary for BENZYL BENZOATE
| US Patents: | 0 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 138 |
| Clinical Trials: | 4 |
| Patent Applications: | 6,882 |
| DailyMed Link: | BENZYL BENZOATE at DailyMed |
Recent Clinical Trials for BENZYL BENZOATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| E-DA Hospital | Phase 2 |
| Medical University of Vienna | Phase 4 |
| Centre de Recherche Médicale de Lambaréné | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for BENZYL BENZOATE
US Patents and Regulatory Information for BENZYL BENZOATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lannett | BENZYL BENZOATE | benzyl benzoate | EMULSION;TOPICAL | 084535-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
